NCT03494907View on ClinicalTrials.gov

A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions

Healthy

Interventions

DRUG

Seltorexant

Participants will be administered oral dose of seltorexant over-encapsulated tablets on Day 1.

OTHER

Placebo Matched to Seltorexant

Participants will be administered matching placebo to seltorexant tablets on Day 1.

OTHER

Placebo Matched to Moxifloxacin

Participants will be administered oral dose of moxifloxacin placebo tablet on Day 1.

DRUG

Moxifloxacin Dose 1

Participants will be administered oral dose 1 of moxifloxacin on Day 1.

Trial Locations (1)

2170

Clinical Pharmacology Unit, Merksem

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT03494907 - A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants | Biotech Hunter | Biotech Hunter